Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
about
Overprescribing proton pump inhibitorsThe role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitorsStrategies for discontinuation of proton pump inhibitors: a systematic reviewProton pump inhibitors: potential cost reductions by applying prescribing guidelines.Do proton pump inhibitors decrease calcium absorption?Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 surveyProton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.Use of proton pump inhibitors and risk of osteoporosis-related fractures.Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study.A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD).Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study.Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction.Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint.Gastroesophageal reflux disease in children and adolescents: when and how to treat.Systematic review: hypomagnesaemia induced by proton pump inhibition.Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment.Esophagitis in children: an update on current pharmacotherapy.The regulation of gastric acid secretion - clinical perspectives.Comparative safety and efficacy of proton pump inhibitors in paediatric gastroesophageal reflux disease.Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease.Discontinuation of proton pump inhibitor therapy and the role of esophageal testingProton pump inhibitor prescribing patterns in the UK: a primary care database study.Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future.Outcome after Discontinuation of Proton Pump Inhibitors at a Residential Care Site: Quality Improvement Project.Placebo-Controlled Discontinuation of Long-Term Acid-Suppressant Therapy: A Randomised Trial in General Practice.Oral proton-pump inhibitors and step-down therapy for nonulcer dyspepsia: is this the right approach?The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the rat.When to stop?Long-term gastric changes in achlorhydric H(+)/K(+)-ATPase beta subunit deficient mice.Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial.Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications.A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.Response: Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.Evidence-based clinical practice guidelines for functional dyspepsia.Internists' Perceptions of Proton Pump Inhibitor Adverse Effects and Impact on Prescribing Practices: Results of a Nationwide Survey.Proton-pump inhibitors among adults: a nationwide drug-utilization study.Is There a Reason for the Proton Pump Inhibitor? An Assessment of Prescribing for Residential Care Patients in British Columbia
P2860
Q24669995-A4EC5B9D-940B-4BBD-B7AF-24FFBDCDA58BQ26866168-777D3732-121D-4EC9-AAE0-A61A9C94AD91Q27022227-23A6957A-691A-444C-AC7C-DF89C1824E5EQ34481174-DAA55FA2-43E2-4CDE-BFEC-F2612C139B8CQ35229828-507BAAA9-3CAF-421E-8767-27541F948F18Q35268223-F26BA3A4-85A3-4B49-BC17-37D93F9BF4C3Q36635329-1E02557D-9A55-41C9-9039-B49F26B72AF3Q36803505-E751630B-9247-485B-9457-542BB617014FQ37156178-65794EF1-A618-4E27-9D36-0FAD4C7E93E2Q37160360-2CFCBCA0-8D75-4DF4-84DF-F81818A8994DQ37173748-00B4B2A5-0C0B-4220-B327-10DE3432C902Q37639328-4E9E0E79-092A-46C9-BE6B-A30BDF9B03EBQ37650556-CA30D4E7-A6FA-4D17-9FC8-458D8476D14AQ37960158-A8103084-96A9-415B-B128-39207305D443Q38023882-93C194BD-6E51-41FE-9DA9-B3BB6A590117Q38073333-12AC742A-AEE8-4377-9DDF-4919E8889400Q38153767-F6648FA3-59BC-4D74-A7D4-D2661E12C3DAQ38166450-273BD543-CC8A-470D-BD4E-F9FFD17FCD16Q38202595-F1623ADD-0E94-4A65-8057-AF4D8E3119A0Q38266846-D16E33EC-6520-47D4-B940-800052F12F52Q38668590-BB23CFF5-9F66-4ECB-B0FF-C1192ED41153Q38887035-CF89AFEB-D48A-4407-B689-03ABFE10C487Q39714357-DF76F308-BB36-425C-AA00-7DCCABC06411Q39940166-8E0B1B93-8EF4-4FB7-915D-3E883E18241CQ40146435-0A8DC1A1-B36B-4ACC-9290-87B6D53892B8Q40655375-62A30FB3-8ED9-4609-A547-D9BEC4BDA174Q41174311-3EE9D275-8210-45BB-B44E-F83B87764EA3Q42123431-2568F4E5-E073-46CE-A91B-29151AC353BCQ42993505-FE4140D5-ABAD-41FA-86AA-16C5CFD85841Q43061734-CD8C3C01-E6F8-4BD3-AEDD-A1177CEFF2B6Q43120420-5FD224A2-28CC-4592-A0D8-D6366CB527AAQ43178513-36EE70B8-AE91-46EF-B64B-EB236593233FQ48124606-D76872E2-E00D-4BC0-BE14-2ACAE455C51BQ48339316-9C2C669D-6C98-4DC6-8B20-6129F1BBE199Q50977089-44F42215-80BC-4A83-AFAB-3AA9850A245CQ55113683-FF770B97-35E0-4E9D-891A-3400648ABCE1Q55289788-87EC01F4-D6B4-40BB-B24D-8C8238EBCA66Q58557258-137CA35F-7FF6-4D12-8387-6C773C466A95
P2860
Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Discontinuation of proton pump ...... ind, placebo-controlled trial.
@en
Discontinuation of proton pump ...... ind, placebo-controlled trial.
@nl
type
label
Discontinuation of proton pump ...... ind, placebo-controlled trial.
@en
Discontinuation of proton pump ...... ind, placebo-controlled trial.
@nl
prefLabel
Discontinuation of proton pump ...... ind, placebo-controlled trial.
@en
Discontinuation of proton pump ...... ind, placebo-controlled trial.
@nl
P2093
P2860
P1476
Discontinuation of proton pump ...... lind, placebo-controlled trial
@en
P2093
Abrahamsson H
Agerforz P
Björnsson E
Kilander A
P2860
P304
P356
10.1111/J.1365-2036.2006.03084.X
P407
P577
2006-09-01T00:00:00Z